Med Spa Medical Director Cost & Agreement 2026: What to Pay, What to Sign, and How to Stay Compliant

Almost every med spa in the United States needs a medical director or supervising physician, yet two questions about that relationship are answered badly more often than any other in the industry: what should you pay, and what should the contract say. Owners routinely overpay for absentee figureheads, underpay for genuine oversight they then fail to document, or — most dangerously — structure compensation in a way that quietly violates fee-splitting and corporate-practice rules. In 2026 the cost of getting this wrong has risen sharply, because the regulatory environment has turned decisively against the nominal, license-on-paper arrangement that defined the industry's first two decades.

This pillar is the national reference on the economics and the contract of a med spa medical director. It synthesizes six state-specific deep dives we published over the past week — covering California, New York, Texas, Florida, Arizona, and Georgia — into one navigable resource. It tells you what a director costs at fair market value, what every compliant agreement must contain, why the pay can never be tied to revenue, how the rent-a-doc model is collapsing under coordinated 2026 enforcement, and how the rules differ state by state. Each section links to the underlying state guide where the operational detail lives, and to the national frameworks that sit beneath all of it.

The 2026 Medical Director Landscape — Cost, Contract, and the End of Rent-a-Doc

For most of the med spa industry's history, the medical director relationship was treated as a checkbox. A practice found a physician willing to lend a license, paid a small flat fee, filed a one-page agreement, and never thought about it again until something went wrong. That era is structurally over. Three forces converged in 2026 to make the medical director relationship the single most scrutinized element of med spa compliance.

The Three Forces Reshaping the Relationship

First, cost transparency. The market has matured to the point where fair-market-value benchmarks for medical director compensation are well established, which means both underpayment (a signal of a sham arrangement) and revenue-tied payment (a signal of fee-splitting) now stand out to regulators and plaintiffs' attorneys. Second, contract scrutiny. State boards and health agencies increasingly ask to see the actual agreement during inspections, and a thin or boilerplate contract is read as evidence the oversight is equally thin. Third, the genuine-oversight standard. Every major market now measures the relationship by what the practice can document — chart reviews, protocols, site visits, reachability — rather than by what the contract recites.

Why the Rent-a-Doc Model Is Collapsing

The rent-a-doc model — a physician who collects a fee but performs no real oversight — is collapsing because regulators stopped accepting the paper and started demanding the substance. Georgia's Composite Medical Board took the most direct action, banning the matchmaker platforms that broker these arrangements. California reaches the same conduct through SB 351's corporate-practice enforcement. New York, Texas, and Florida all apply a genuine-supervision test that an absentee physician fails. The result is a national convergence: the only safe medical director is a real one, priced fairly and documented thoroughly.

How to Read This Pillar

Use this pillar to orient on the universal principles — cost, contract contents, fee-splitting, the rent-a-doc crackdown, and genuine oversight — then drill into the state guide that governs your practice. The national frameworks on medical director requirements and medical director liability sit beneath everything here, and the broader 2026 state regulatory year-in-review shows how the medical director shift fits the wider enforcement picture.

What a Med Spa Medical Director Actually Costs in 2026 (National FMV Overview)

The single most common question owners ask is the simplest to answer in a range and the hardest to answer precisely: what does a medical director cost? In 2026, the national range runs from roughly $1,500 to $8,000 or more per month, with hourly arrangements commonly at $200 to $500 per hour. Where a given practice lands inside that range depends on three variables: the depth of oversight, the state, and the physician's qualifications and exposure.

Pricing by Depth of Oversight

The biggest driver is how much the physician actually does. A nominal supervisory tier — protocol sign-off, emergency availability, periodic remote chart review, no routine on-site presence — typically runs $1,500 to $3,000 per month. A standard part-time tier with regular chart review, monthly or biweekly site visits, and active protocol maintenance runs $3,000 to $6,000. A hands-on tier, where the physician is regularly on site, performs procedures, conducts good-faith exams, and is deeply involved in clinical operations, runs $6,000 to $10,000 or more. The key compliance point: the price must track the work. Paying a nominal fee for a tier you then claim is active oversight invites scrutiny, and so does the reverse.

Pricing by State

Geography matters because both the cost of physician labor and the intensity of the supervision requirement vary. California and New York sit at the top of the range, reflecting high physician wages and the most demanding oversight regimes. Texas and Georgia sit in the middle. Arizona and Florida tend to run lower, with Arizona's full-practice-authority backdrop sometimes removing the need for a supervising physician entirely. The state-by-state comparison later in this pillar puts concrete monthly ranges next to each market, and each state agreement guide breaks the figures down further.

Retainer vs. Hourly vs. Per-Site

Most arrangements use a flat monthly retainer because it is administratively simple and easy to defend as fair market value. Hourly arrangements ($200–$500/hr) suit practices with variable or low volume, but require disciplined time logs. Per-site pricing appears in multi-location groups, where a physician supervises several locations under a single agreement with a per-site add-on. Whatever the structure, the compensation must be a fixed, predetermined amount unconnected to the practice's revenue or patient volume — the moment it floats with revenue, it becomes fee-splitting. For the underlying qualification and scope framework, see our national guide on med spa medical director requirements.

What Drives a Director to the Top of the Range

Beyond depth and geography, individual factors push compensation up: board certification in a relevant specialty, willingness to perform good-faith exams and procedures personally, sole-director exclusivity (rather than splitting attention across many practices), and assumption of broader clinical responsibility. A physician who treats the role as genuine clinical accountability commands more — and is worth more, because that same engagement is exactly what protects the practice during an inspection or lawsuit. The American Med Spa Association's resources at americanmedspa.org track evolving compensation norms across markets.

What Every Compliant Medical Director Agreement Must Contain

If cost is the question owners ask first, the contract is the one they should ask second. The medical director agreement is the document regulators request first during an inspection, the document plaintiffs' attorneys dissect after an adverse event, and the document that determines whether your supervision defense holds. A compliant agreement is not a one-page license rental; it is a detailed instrument that defines a real working relationship. Below are the clauses every agreement must contain.

Scope of Clinical Oversight

The agreement must specify exactly what the physician is responsible for: which service lines they oversee, which procedures fall under their delegation, and the boundaries of their clinical authority. Vague language ("general oversight of the practice") is a red flag. The scope should name the treatment categories — injectables, lasers, weight-loss pharmacotherapy, IV therapy — and tie each to the physician's authorization.

Supervision Schedule and Chart-Review Cadence

The contract must state how often the physician reviews charts, conducts site visits, and is available for consultation. A defined cadence — for example, weekly chart review of a percentage of cases plus a monthly on-site visit — converts an abstract duty into a documentable commitment. This is the single clause most likely to be tested during an inspection, because the genuine-oversight standard is measured precisely here.

Fair-Market-Value Compensation

Compensation must be a fixed retainer or documented hourly rate set at fair market value, expressly unconnected to revenue, patient volume, or referrals. The clause should state the amount, the payment schedule, and the basis (the oversight services delivered), and should ideally reference periodic FMV review. This is the clause that keeps the agreement on the right side of fee-splitting and corporate-practice law — the subject of the next section.

Delegation, Protocols, and Standing Orders

The agreement must identify which procedures are delegated to which categories of staff (RN, NP, PA, esthetician) and reference the protocols or standing orders that authorize them. It should obligate the physician to develop, approve, and periodically update treatment protocols, and to sign the state-specific supervision instrument — California Patient-Specific Orders, Texas standing delegation orders or PAAs, Arizona written provider orders, Georgia nurse protocol agreements. Our guide on the med spa policy and procedure manual covers how these protocols nest inside the broader documentation system.

Emergency Availability, Insurance, and Termination

Finally, the agreement must address emergency and adverse-event availability (how staff reach the physician and how complications are escalated), malpractice coverage and indemnification (who carries what and at what limits), and term, termination, and post-termination obligations (notice periods, record handling, and continuity of patient care). For a full treatment of what the physician personally assumes by signing, see our national guide on medical director liability. The state deep dives — for example the New York agreement guide — show how each clause is tuned to a specific state's law.

Why Compensation Cannot Be Tied to Revenue — Fee-Splitting and Anti-Kickback

Of every rule in this pillar, the one owners violate most often without realizing it is the prohibition on revenue-tied compensation. It feels natural to pay a medical director a percentage of the revenue they help generate — it aligns incentives, the logic goes. In healthcare, that intuition is exactly backwards and exactly illegal in most states. Understanding why is essential, because the structure of the payment, not just its amount, determines compliance.

What Fee-Splitting Means

Fee-splitting is the sharing of professional medical fees between a licensed provider and a non-physician or a non-physician-owned business. Most states with a corporate-practice-of-medicine doctrine prohibit it because it lets a lay-owned business profit from the practice of medicine and creates incentives that can compromise clinical judgment. When a med spa pays its medical director a percentage of treatment revenue, it is splitting professional fees — the classic prohibited arrangement. The fix is structural: a flat, predetermined retainer that does not move with what the practice earns.

How Anti-Kickback Law Compounds the Risk

Where federal healthcare programs, referrals, or certain drugs are involved, the federal Anti-Kickback Statute adds a second layer of exposure. Compensation tied to the volume or value of business generated can be construed as remuneration for referrals. Even in cash-pay aesthetic practices that touch no federal program, state anti-kickback and fee-splitting analogs frequently apply, and the structural logic is the same: pay for oversight delivered, not for business generated. The Hinshaw & Culbertson overview of med spa compliance pitfalls walks through how fee-splitting and supervision failures intersect.

Why Revenue-Tied Pay Signals a Sham

Beyond the direct illegality, revenue-tied compensation tells regulators a story they are primed to believe: that the physician is a passive profit participant rather than an independent clinical supervisor. It suggests the physician's interest is in volume, not safety — the opposite of the oversight the relationship is supposed to provide. That inference colors everything else in an investigation, which is why even arrangements that might survive a narrow legal test are dangerous in practice.

The Compliant Alternative

The compliant structure is straightforward: a fixed monthly retainer or a documented hourly rate, set at fair market value for the oversight actually performed, reviewed periodically, and entirely unconnected to revenue, treatment counts, or referrals. If the practice grows and the oversight workload grows with it, the retainer can be renegotiated upward to reflect the additional work — but it is renegotiated to the work, not indexed to the revenue. This distinction is subtle in feel and decisive in law. Every state agreement guide in this cluster reinforces it.

The Rent-a-Doc Crackdown — Georgia's Matchmaker Ban and the National Trend

The defining medical director story of 2026 is the collapse of the rent-a-doc model. For years, a thriving market of platforms and individual physicians offered med spas a simple product: a license to satisfy the supervision requirement, with as little actual involvement as possible. That product is now in regulatory crosshairs across the country, and Georgia's action is the leading edge.

What Rent-a-Doc Actually Means

A rent-a-doc medical director provides a license and a signature but little else — no routine chart review, no protocol authorship, no site visits, often no reachability during operating hours. The physician may supervise dozens of unrelated practices they have never visited. The arrangement satisfied the letter of the supervision requirement while hollowing out its substance. It was cheap, frictionless, and — until recently — widely tolerated. The problem is that when an adverse event occurs, the absent physician carries the malpractice and board exposure while the practice discovers its supervision defense was never real.

Georgia's May 7 GCMB Matchmaker Ban

On May 7, 2026, the Georgia Composite Medical Board issued a Position Statement that, among other provisions, expressly prohibits payments to third-party supervising-physician matching services where the platform is paid for access to a delegating physician and that physician is also compensated through the arrangement to supervise or delegate to an APRN. This is the first explicit, categorical state ban on the matchmaker structure. It does not outlaw legitimate physician staffing or recruitment — it targets platforms that profit from the supervisory relationship itself. The full analysis is in our Georgia medical director agreement guide, and the National Law Review's coverage of the GCMB action details the legal mechanics.

How Other States Reach the Same Conduct

Georgia is the first to ban the model by name, but it is not alone in reaching it. California's SB 351 attacks rent-a-doc structures through corporate-practice enforcement against MSOs that exert clinical control, as the Epstein Becker Green analysis of SB 351 explains. New York's multi-agency task force targets ghost medical directors during inspections, as documented in the NY Department of State enforcement announcement. Texas's written-delegation requirements under TMB Rule 169.28 make absentee supervision documentable and therefore enforceable. Florida's AHCA cites ghost medical directors under existing authority.

The National Trajectory

Read together, these actions describe a national trajectory: the regulatory tolerance that allowed rent-a-doc to flourish is evaporating, and the model is migrating from standard practice to active liability. Operators relying on a matchmaker-arranged absentee supervisor should treat 2026 as the year to restructure into a direct physician contract or a legitimate staffing placement. The broader sweep of these changes is mapped in our 2026 state regulatory changes pillar.

State-by-State Comparison: Cost, Fee-Splitting Posture, and Key Rules

The principles above are national, but the figures and the specific rules vary by state. The table below compares the six markets covered in this cluster on three dimensions: typical monthly FMV range, fee-splitting and corporate-practice posture, and the headline 2026 rule shaping the medical director relationship. Each row links to the full state agreement guide.

Reading the Comparison

Two patterns stand out. First, the FMV ranges cluster tightly — there is no state where a real medical director is cheap, and the gap between the top (California, New York) and the bottom (Arizona, Florida) is a factor of roughly two, driven by physician wages and supervision intensity rather than by any state being lax. Second, every state, through a different doctrinal route, lands on the same place: the physician must be real, must be paid at FMV without revenue ties, and must be documentable. The mechanisms differ; the destination is identical.

Where the States Diverge Most

The sharpest divergence is Arizona, where full practice authority for nurse practitioners can remove the need for a physician medical director entirely — an NP can own the practice and serve as the responsible provider. That makes Arizona structurally different from the corporate-practice states, even though the documentation discipline is the same. The other major divergence is enforcement posture: New York's inspection task force and Georgia's matchmaker ban are active, named actions, while Florida operates through the steady application of existing AHCA authority. Each market's full resource set lives at its state hub — New York, Texas, Florida, and Arizona. For the full multi-state framework, see our med spa regulations by state reference.

CPOM and Ownership — How It Shapes the Medical Director Relationship

You cannot understand medical director cost or contract structure without understanding the corporate practice of medicine (CPOM), because CPOM determines who can own the practice, who can employ the physician, and how money can legally flow between them. The medical director relationship looks very different in a strict CPOM state than in a state without the doctrine.

What CPOM Requires

The corporate practice of medicine doctrine, in the states that follow it, prohibits non-physicians and lay-owned corporations from owning medical practices or employing physicians to practice medicine. In those states, a med spa offering medical treatments must typically be structured as a physician-owned professional entity, often paired with a management services organization (MSO) that handles non-clinical operations under a management services agreement. The medical director or physician-owner holds clinical authority; the MSO handles administration without crossing into clinical decisions.

How CPOM Shapes Compensation

CPOM is the reason compensation cannot be revenue-tied. In a CPOM state, the lay-owned MSO cannot share in professional fees, so payment to the physician — and payment from the practice to the MSO — must be structured as fair-market-value compensation for defined services, not as a split of clinical revenue. California's SB 351 sharpened this in 2026 by voiding many MSO non-competes and barring MSOs from clinical control, as our California agreement guide details. The structure of the entity and the structure of the pay are inseparable.

The Friendly-PC / MSO Model

The dominant structure in strict CPOM states is the "friendly PC" model: a physician owns the professional corporation that delivers care, while an MSO owned by the business operators provides everything non-clinical under an arm's-length management agreement. The medical director is often the friendly-PC owner or a contracted physician within it. Getting this structure right is a legal exercise that should involve a healthcare attorney — the penalties for getting it wrong include voided contracts, disgorgement, and board discipline.

Ownership in Non-CPOM and FPA States

In states without a strict CPOM bar, or in full-practice-authority states like Arizona, the calculus changes. A nurse practitioner with full practice authority can own the med spa and serve as the responsible clinical provider, sometimes eliminating the need for a separate physician medical director. Our pillar on nurse practitioner med spa ownership maps which of the 27 NP-friendly states permit which models. Even there, the practice needs a documented clinical leader — the title changes, the oversight obligation does not.

Genuine Oversight — The Documentation Regulators Now Demand

The phrase that unifies every 2026 state change is "genuine oversight." It is the standard Georgia's GCMB wrote into its Position Statement, the standard New York's task force enforces during inspections, and the standard implied by California's Patient-Specific Orders and Arizona's written provider orders. Understanding what genuine oversight means in practice — and how to document it — is the core defensive skill for any med spa in 2026.

Genuine Oversight Is Measured by Documentation

The decisive shift is that regulators no longer accept the contract as proof of oversight. They ask what the physician actually did, and they expect a paper trail: dated chart-review logs, signed protocols, site-visit records, telehealth supervision notes, and per-patient authorizations. An arrangement with a perfect contract but an empty file is treated as no supervision at all. Conversely, a modest arrangement with thorough documentation is defensible. The lesson is that documentation is not paperwork overhead — it is the oversight, made visible.

The Genuine-Oversight Evidence File

A practice can demonstrate genuine oversight by maintaining, and producing on demand, a defined evidence set: a signed and current medical director agreement; current treatment protocols bearing the physician's signature; chart-review logs with dates and case identifiers; records of on-site visits or telehealth supervision sessions; a documented method for staff to reach the physician during operating hours; and individualized written orders or good-faith exams for each patient before treatment. This file is what an inspector asks to see, and the speed and completeness with which you can produce it determines the outcome. Our med spa inspection guide details exactly what inspectors check.

Per-Patient Authorization Is Replacing Standing Orders

A specific component of genuine oversight is the move from generic standing orders to per-patient authorization. California requires Patient-Specific Orders for every encounter; Arizona requires written provider orders for Level II/III procedures; Texas requires written delegation through standing orders, protocols, or PAAs; Georgia's genuine-oversight language implies patient-level documentation. The common operational outcome is that every Level II/III treatment now needs an individualized written order in the chart before a delegated provider acts. Generic "all qualifying patients" standing orders are no longer sufficient where they once were.

Building Oversight Into the Workflow

The practices that handle this best build oversight into the daily workflow rather than reconstructing it before an inspection. A standing cadence — chart review every week, a monthly site visit, a good-faith exam before every new patient's first treatment — generates the documentation as a byproduct of doing the work. The policy and procedure manual is where this cadence is codified, so it survives staff turnover and is enforced consistently.

How to Find and Vet a Medical Director (and Red Flags)

Knowing what to pay and what to sign is only useful if you can find a physician who will actually do the job. Sourcing and vetting a medical director is where many owners default to the cheapest, easiest option — exactly the rent-a-doc trap. A disciplined process produces a director who protects the practice rather than one who quietly endangers it.

Where to Source Candidates

The best sources are direct physician contracts (often through professional networks or local relationships), legitimate healthcare staffing firms that place physicians for genuine supervisory work, referrals from other compliant practices, and aesthetic-medicine professional associations. The source to avoid is the fee-per-supervisor matchmaker platform — the exact model Georgia banned and the others are squeezing. A legitimate staffing firm places a physician who supervises; a matchmaker platform profits from brokering a license. The distinction is now legally consequential.

What to Vet For

Verify an active, unrestricted license in your state; confirm relevant aesthetic or supervisory experience; check board history for discipline; confirm adequate malpractice coverage; and assess genuine willingness to review charts, visit the site, and be reachable. Critically, ask how many other practices the physician supervises — a director spread across dozens of unrelated sites cannot provide genuine oversight to any of them, and that overextension is itself a liability. The qualification framework in our medical director requirements guide details the credentials to confirm.

Red Flags That Should End the Conversation

Several signals should disqualify a candidate immediately: refusal to perform chart review; a request to be paid a percentage of revenue or per treatment; supervision of an implausibly large number of unrelated practices; reluctance to put scope, cadence, and availability in writing; and any suggestion that the relationship is "just paperwork." Each of these is a marker of the rent-a-doc model, and each transfers risk to the practice while providing none of the protection the relationship is supposed to deliver.

Aligning Incentives the Right Way

The right director treats the role as clinical responsibility, not passive license rental. Aligning incentives means paying fairly for real work, giving the physician the access and information needed to supervise, and treating their clinical input as authoritative rather than as a formality to be managed around. A director who is genuinely engaged is the practice's best defense — and, not coincidentally, the structure every 2026 regulator is pushing the industry toward. The liability framework in our medical director liability guide explains why engaged directors protect both parties.

Special Cases: Full Practice Authority States and When You May Not Need an MD

The default assumption — that every med spa needs a physician medical director — is not universally true. A meaningful set of states grant nurse practitioners full practice authority, and in those states the medical director question has a different answer. Owners in these markets should understand the option, because it changes both the cost structure and the compliance model.

What Full Practice Authority Means

Full practice authority (FPA) allows a nurse practitioner to evaluate patients, diagnose, order tests, and prescribe — including controlled substances in most FPA states — without physician supervision or a collaborative agreement. In an FPA state, an NP can own a med spa, serve as the responsible clinical provider, author protocols, and issue the written orders that authorize treatment. There is no statutory need for a separate physician medical director, which can remove a significant recurring cost.

Arizona as the Model

Arizona is the clearest example in this cluster. NPs hold full practice authority, can own and operate med spas independently, and can issue the written provider orders the Board of Nursing's Advisory Opinion now requires for Level II/III procedures. The documentation discipline is identical to a physician-led practice — protocols, chart review, written orders — but the institutional flexibility is greater and the cost of a supervising physician can be eliminated. Our Arizona agreement guide covers the FPA structure in detail, and the national NP ownership pillar maps the broader landscape.

When You Still Need Physician Involvement

Even in FPA states, physician involvement may still be required for specific procedures, for certain laser or device categories regulated separately, or when the practice offers services outside the NP's scope. And FPA does not eliminate the oversight obligation — it relocates it to the NP, who now bears the responsibility a medical director would otherwise carry. The practice still needs a documented clinical leader; FPA simply changes who that leader can be.

Reduced-Authority and Restricted States

In reduced-authority and restricted states, the opposite is true: an NP needs a collaborating or supervising physician, and the med spa needs the full medical director apparatus. The cost and contract analysis in this pillar applies directly. Knowing which category your state falls into is the first structural decision, and it drives everything downstream — see the regulations by state reference for the classification.

What 2027 Will Likely Bring for Medical Director Regulation

The 2026 actions are not an endpoint; they are the opening moves of a multi-year tightening. Forward-looking operators should structure their medical director relationships now to where regulation is heading, not just where it is. Several trajectories are visible.

More States Will Ban or Restrict Matchmaker Models

Georgia's matchmaker ban is replicable and politically attractive — it targets an unsympathetic business model without burdening legitimate practices. Expect other states to issue similar Board position statements or guidance, particularly states with active APP-supervision debates. Practices relying on matchmaker arrangements anywhere should assume the model has a short remaining life and restructure proactively, as our Georgia hub recommends.

Per-Patient Authorization Will Become Universal

The shift from standing orders to per-patient written authorization — already required in California, Arizona, and Texas in various forms — will likely spread. The logic is consistent with the genuine-oversight standard, and it gives regulators a clean, documentable test. Practices that build per-patient authorization into their workflow now will be ahead of the requirement when it arrives in their state.

FMV Scrutiny and Compensation Benchmarking Will Increase

As medical director compensation data matures, expect more scrutiny of arrangements that deviate from FMV — both the suspiciously low fees that signal sham oversight and the revenue-tied structures that signal fee-splitting. Practices should document the basis for their compensation and revisit it periodically against market benchmarks, keeping a written FMV rationale in the file.

Multi-Agency and Federal Enforcement Will Expand

New York's multi-agency model and the FDA's dispenser-level enforcement both point toward a future where a single med spa faces coordinated scrutiny from multiple regulators at once. Medical director documentation sits at the center of that scrutiny, because it is the connective tissue between clinical practice, drug handling, and supervision. The broader forecast is mapped in our 2026 regulatory changes pillar.

Where to Start: Structure, Source, Document, and Budget

The volume of rules in this pillar can feel overwhelming, but the action plan reduces to four sequential decisions. Work through them in order and the medical director relationship resolves from an anxiety into a managed, defensible part of the practice.

Step 1: Get the Structure Right

Determine your state's posture first — strict CPOM, non-CPOM, or full practice authority — because it dictates whether you need a physician medical director, an MSO/friendly-PC structure, or an NP-led model. This is the foundational decision, and it is worth a healthcare attorney's time to get right. The regulations by state reference and your specific state agreement guide — Texas, New York, or another — are the starting points.

Step 2: Source a Real Director

Find a physician (or, in FPA states, confirm your NP) through direct contracts, legitimate staffing, or professional referrals — never a matchmaker platform. Vet for license, experience, board history, malpractice coverage, and genuine willingness to engage. The sourcing discipline in section nine is the difference between a protective relationship and a liability.

Step 3: Document the Oversight

Build the genuine-oversight evidence file from day one: signed agreement, signed protocols, chart-review logs, site-visit records, reachability procedures, and per-patient authorizations. Codify the cadence in your policy and procedure manual so it survives staff turnover. This is the work that converts a contract into a defense.

Step 4: Budget at Fair Market Value

Budget a flat FMV retainer ($1,500–$8,000+/month depending on state and depth) or a documented hourly rate, never a revenue share. Keep a written FMV rationale, and revisit it as the practice grows. The Operations & Compliance Kit gives you the FMV-structured agreement, the supervision and chart-review logs, and the delegation templates to execute all four steps — and the state guides for California, Florida, Arizona, and the rest tailor the budget to your market.

Summary

1. A med spa medical director in 2026 costs roughly $1,500 to $8,000+ per month, or $200–$500 per hour, set at fair market value for the oversight actually delivered
2. Compensation must be a flat retainer or documented hourly rate — never a percentage of revenue, patient volume, or referrals, which constitutes fee-splitting and can implicate anti-kickback law
3. A compliant agreement must define scope, supervision schedule, chart-review cadence, FMV compensation, delegation, protocols, emergency availability, insurance, and termination
4. The rent-a-doc model is collapsing: Georgia's May 7 GCMB Position Statement bans matchmaker supervisor platforms outright, and California, New York, Texas, and Florida reach the same conduct through CPOM and genuine-oversight enforcement
5. CPOM determines who can own the practice and how money can flow, and is the reason compensation cannot be revenue-tied; strict CPOM states require a friendly-PC / MSO structure
6. Genuine oversight is measured by documentation — chart-review logs, signed protocols, site visits, reachability, and per-patient authorization — not by what the contract recites
7. In full-practice-authority states like Arizona, an NP can own and lead the practice without a physician medical director, though the oversight obligation simply relocates to the NP
8. 2027 will likely bring more matchmaker bans, universal per-patient authorization, increased FMV scrutiny, and expanded multi-agency and federal enforcement
9. Start by getting the structure right for your state, sourcing a real director, documenting the oversight from day one, and budgeting a flat FMV retainer

Disclaimer: This article is for educational purposes only and does not constitute legal advice. Medical director compensation and contract requirements vary by state and are actively evolving; verify current requirements with your state medical board, board of nursing, or a licensed healthcare attorney before structuring a medical director relationship. The state-specific guides linked throughout provide deeper analysis of each state's rules.